Momenta Pharmaceuticals (MNTA) PT Raised to $30 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Brandon Folkes raised the price target on Momenta Pharmaceuticals (NASDAQ: MNTA) to $30.00 (from $22.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
